SEARCH

SEARCH BY CITATION

References

  • Barbone, F., McMahon, A. D., Davey, P. G. et al. Association of road-traffic accidents with benzodiazepine use. Lancet, 1998, 352: 13311336.
  • Bond, A. and Lader, M. The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol., 1974, 47: 211218.
  • Curran, H. V., Collins, R., Fletcher, S., Kee, S. C. Y., Woods, B. and Iliffe, S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol. Med., 2003, 33: 12231237.
  • Deacon, S., Staner, L., Staner, C., Vorstrup, S. and Lundahl, J. Acute administration of gaboxadol improves sleep initiation and maintenance in patients with primary insomnia. Sleep, 2005, 28: A240.
  • Deacon, S., Staner, L., Staner, C., Legters, A., Loft, H. and Lundahl, J. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep, 2007, 30: 281287.
  • Ebert, B., Wafford, K. A. and Deacon, S. Treating insomnia: current and investigational pharmacological approaches. Pharmacol. Ther., 2006, 112: 612629.
  • Faulhaber, J., Steiger, A. and Lancel, M. The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology, 1997, 130: 285291.
  • Jex, H. R., Mcdonnell, J. D. and Phatak, A. V. A ‘critical’ tracking task for man–machine research related to the operator’s effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep. NASA CR, 1966, 1105.
  • Kapteyn, T. S., Bles, W., Njiokiktjien, C. J., Kodde, L., Massen, C. H. and Mol, J. M. Standardization in platform stabilometry being part of posturography. Agressologie, 1983, 24: 321326.
  • Lancel, M., Wetter, T. C., Steiger, A. and Mathias, S. Effect of the GABAA agonist gaboxadol on nocturnal sleep and hormone secretion in healthy elderly subjects. Am. J. Physiol. Endocrinol. Metab., 2001, 281: E130E137.
  • Louwerens, J. W., Gloerich, A. B. M., De Vries, G., Brookhuis, K. A. and O’Hanlon, J. F. The relationship between drivers’ blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: P. C.Noordzij and R.Roszbach (Eds) International Congress on Alcohol, Drugs and Traffic Safety, T86. Exerpta Medica, Amsterdam, 1987: 183186.
  • Lund, J., Lundahl, J., Nielsen, G. M. and Mengel, H. The pharmacokinetic properties of gaboxadol, a new hypnotic, in young and elderly men. Sleep, 2005, 28: A48.
  • Lund, J., Helboe, T. and Mengel, H. Absorption, metabolism, and excretion profile of gaboxadol in humans. Sleep, 2006, 29: A41.
  • Lundahl, J., Staner, L., Staner, C. and Deacon, S. The selective extrasynaptic GABAa agonist, gaboxadol, improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. J. Sleep Res., 2006, 15: 194195.
  • Mathias, S., Steiger, A. and Lancel, M. The GABAa agonist gaboxadol improves the quality of post-nap sleep. Psychopharmacology, 2001, 157: 299304.
  • Mathias, S., Zihl, J., Steiger, A. and Lancel, M. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects. Neuropsychopharmacology, 2005, 30: 833841.
  • Moskowitz, H. Laboratory studies of the effects of alcohol on some variables related to driving. J. Safety Res., 1973, 5: 185199.
  • Mulder-Hajonides Van Der Meulen, W. R. E. H. Measurement of Subjective Sleep Quality. Elsevier, Amsterdam, 1981.
  • Neutel, I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum. Psychopharmacol. Clin., 1998, 13: S115S123.
  • O’Hanlon, J. F. Driving performance under the influence of drugs: rationale for, and application of, a new test. Br. J. Clin. Pharmacol., 1984, 18(Suppl. 1): 121s129s.
  • Ramaekers, J. G., Muntjewerff, N. D., Uiterwijk, M. M. C. et al. A study of the pharmacodynamic interaction between befloxatone and ethanol on performance and mood in healthy volunteers. J. Psychopharmacol., 1996, 10: 288294.
  • Rey, A. L’examen clinique en psychologie. Presses Universitaires de France, Paris, 1964.
  • Sanders, A. F. Towards a model of stress and human performance. Acta Psychol., 1983, 53: 6197.
  • Savic, M. M., Obradovic, D. I., Ugresic, N. D. and Bokonjic, D. R. Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes. Neural Plast., 2005, 12: 289298.
  • Schultz, B., Aaes Jorgensen, T., Bogeso, K. P. and Jorgensen, A. Preliminary studies on the absorption, distribution, metabolism, and excretion of THIP in animal and man using 14C-labelled compound. Acta Pharmacol. Toxicol., 1981, 49: 116124.
  • Storustovu, S. I. and Ebert, B. Pharmacological characterization of agonists at delta-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. J. Pharmacol. Exp. Ther., 2006, 316: 13511359.
  • Swainston Harrison, T. and Keating, G. M. Zolpidem: a review of its use in the management of insomnia. CNS Drugs, 2005, 19: 6589.
  • Vermeeren, A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs, 2004, 18: 297328.
  • Vermeeren, A., O’Hanlon, J. F., Declerck, A. C. and Kho, L. Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Ther., 1995, 21: 4764.
  • Vermeeren, A., Danjou, P. E. and O’Hanlon, J. F. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum. Psychopharmacol., 1998, 13: S98S107.
  • Vermeeren, A., Riedel, W. J., Van Boxtel, M. P., Darwish, M., Paty, I. and Patat, A. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep, 2002, 25: 224231.
  • Verster, J. C., Volkerts, E. R., Schreuder, A. H. et al. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance. J. Clin. Psychopharmacol., 2002, 22: 576583.
  • Verster, J. C., Veldhuijzen, D. S. and Volkerts, E. R. Residual effects of sleep medication on driving ability. Sleep Med. Rev., 2004, 8: 309325.
  • Verster, J. C., Volkerts, E. R., Olivier, B., Johnson, W. and Liddicoat, L. Zolpidem and traffic safety – the importance of treatment compliance. Curr. Drug Saf., 2007, 2: 220226.
  • Walsh, J. K., Deacon, S., Dijk, D. J. and Lundahl, J. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia. Sleep, 2007, 30: 593602.